发明名称 (4-PHENYL-PIPERIDIN-1-YL)-[5-1H-PYRAZOL-4YL)-THIOPHEN-3-YL]-METHANONE COMPOUNDS AND THEIR USE
摘要 <p>The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain (4-phenyl-piperidin-1-yl)- [5-(1 H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds that, inter alia, inhibit 11 ß-hydroxysteroid dehydrogenase type 1 (11 ß-HSD1 ). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 1 1 ß-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11 ß-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.</p>
申请公布号 WO2011033255(A1) 申请公布日期 2011.03.24
申请号 WO2010GB01732 申请日期 2010.09.14
申请人 THE UNIVERSITY OF EDINBURGH;WEBSTER, SCOTT, PETER;SECKL, JONATHAN, ROBERT;WALKER, BRIAN, ROBERT;WARD, PETER;PALLIN, THOMAS, DAVID;DYKE, HAZEL, JOAN;PERRIOR, TREVOR, ROBERT 发明人 WEBSTER, SCOTT, PETER;SECKL, JONATHAN, ROBERT;WALKER, BRIAN, ROBERT;WARD, PETER;PALLIN, THOMAS, DAVID;DYKE, HAZEL, JOAN;PERRIOR, TREVOR, ROBERT
分类号 C07D409/14;A61K31/4439;A61P3/00;C07D451/02;C07D451/06 主分类号 C07D409/14
代理机构 代理人
主权项
地址